Cum­mings trig­gers probe in­to pric­ing prac­tices of dozen ma­jor drug­mak­ers

An in­ves­ti­ga­tion in­to drug price goug­ing by the pro­lif­ic chair­man of the Com­mit­tee on Over­sight and Re­form Eli­jah Cum­mings kicked off on Mon­day with in­quiries sent to a dozen ma­jor drug­mak­ers seek­ing in­for­ma­tion on pric­ing prac­tices, days af­ter a leg­isla­tive pack­age aimed at curb­ing sky­rock­et­ing pre­scrip­tion drug prices was un­veiled.

The probe is de­signed to un­pack the ra­tio­nale be­hind dra­mat­ic drug price hikes, how the pro­ceeds from drug sales are be­ing used by man­u­fac­tur­ers and what can be done to cut prices.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER